133 related articles for article (PubMed ID: 34949765)
21. Cytomorphologic features of SMARCA4-deficient non-small cell lung carcinoma and correlation with immunohistochemical and molecular features.
Sun T; Gilani SM; Podany P; Harigopal M; Zhong M; Wang H
Cancer Cytopathol; 2022 Aug; 130(8):620-629. PubMed ID: 35468657
[TBL] [Abstract][Full Text] [Related]
22. [Gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
[No Abstract] [Full Text] [Related]
23. Precision oncology for intrahepatic cholangiocarcinoma in clinical practice.
Tomczak A; Springfeld C; Dill MT; Chang DH; Kazdal D; Wagner U; Mehrabi A; Brockschmidt A; Luedde T; Naumann P; Stenzinger A; Schirmacher P; Longerich T
Br J Cancer; 2022 Nov; 127(9):1701-1708. PubMed ID: 35986087
[TBL] [Abstract][Full Text] [Related]
24. The Prognostic Value of Cytokeratin and Sal-Like Protein 4 Expression in Hepatocellular Carcinoma and Intra-Hepatic Cholangiocarcinoma in Taiwan.
Lai YS; Cheng CC; Lee MT; Chao WT; Lai YC; Hsu YH; Liu YH
Int J Med Sci; 2018; 15(14):1746-1756. PubMed ID: 30588199
[No Abstract] [Full Text] [Related]
25. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.
Jiao Y; Pawlik TM; Anders RA; Selaru FM; Streppel MM; Lucas DJ; Niknafs N; Guthrie VB; Maitra A; Argani P; Offerhaus GJA; Roa JC; Roberts LR; Gores GJ; Popescu I; Alexandrescu ST; Dima S; Fassan M; Simbolo M; Mafficini A; Capelli P; Lawlor RT; Ruzzenente A; Guglielmi A; Tortora G; de Braud F; Scarpa A; Jarnagin W; Klimstra D; Karchin R; Velculescu VE; Hruban RH; Vogelstein B; Kinzler KW; Papadopoulos N; Wood LD
Nat Genet; 2013 Dec; 45(12):1470-1473. PubMed ID: 24185509
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma.
Zhang Z; Li Q; Sun S; Li Z; Cui ZG; Zhang M; Liu Q; Zhang Y; Xiong S; Zhang S
World J Surg Oncol; 2022 Dec; 20(1):383. PubMed ID: 36464671
[TBL] [Abstract][Full Text] [Related]
27. SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas.
Rekhtman N; Montecalvo J; Chang JC; Alex D; Ptashkin RN; Ai N; Sauter JL; Kezlarian B; Jungbluth A; Desmeules P; Beras A; Bishop JA; Plodkowski AJ; Gounder MM; Schoenfeld AJ; Namakydoust A; Li BT; Rudin CM; Riely GJ; Jones DR; Ladanyi M; Travis WD
J Thorac Oncol; 2020 Feb; 15(2):231-247. PubMed ID: 31751681
[TBL] [Abstract][Full Text] [Related]
28. Lymphoepithelioma-Like Carcinoma in Liver.
Labgaa I; Stueck A; Ward SC
Am J Pathol; 2017 Jul; 187(7):1438-1444. PubMed ID: 28500863
[TBL] [Abstract][Full Text] [Related]
29. SMARCA4/BRG1-Deficient Sinonasal Carcinoma.
Kakkar A; Ashraf SF; Rathor A; Adhya AK; Mani S; Sikka K; Jain D
Arch Pathol Lab Med; 2022 Sep; 146(9):1122-1130. PubMed ID: 34871352
[TBL] [Abstract][Full Text] [Related]
30. SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.
Agaimy A; Thiel F; Hartmann A; Fukunaga M
Ann Diagn Pathol; 2015 Oct; 19(5):283-7. PubMed ID: 26123103
[TBL] [Abstract][Full Text] [Related]
31. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.
Sauter JL; Graham RP; Larsen BT; Jenkins SM; Roden AC; Boland JM
Mod Pathol; 2017 Oct; 30(10):1422-1432. PubMed ID: 28643792
[TBL] [Abstract][Full Text] [Related]
32. SMARCB1/INI1 Is Diagnostically Useful in Distinguishing α-Fetoprotein-producing Gastric Carcinoma from Hepatocellular Carcinoma.
Mochizuki K; Kawai M; Odate T; Tahara I; Inoue T; Kasai K; Nakazawa T; Kondo T
Anticancer Res; 2018 Dec; 38(12):6865-6868. PubMed ID: 30504402
[TBL] [Abstract][Full Text] [Related]
33. Diversity in cell differentiation, histology, phenotype and vasculature of mass-forming intrahepatic cholangiocarcinomas.
Nguyen Canh H; Takahashi K; Yamamura M; Li Z; Sato Y; Yoshimura K; Kozaka K; Tanaka M; Nakanuma Y; Harada K
Histopathology; 2021 Nov; 79(5):731-750. PubMed ID: 34018212
[TBL] [Abstract][Full Text] [Related]
34. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.
Sia D; Villanueva A; Friedman SL; Llovet JM
Gastroenterology; 2017 Mar; 152(4):745-761. PubMed ID: 28043904
[TBL] [Abstract][Full Text] [Related]
35. The role of a monoclonal antibody 11C8B1 as a diagnostic marker of IDH2-mutated sinonasal undifferentiated carcinoma.
Dogan S; Frosina D; Fayad M; de Oliveira TB; Alemar B; Rosenblum M; Tang LH; Hameed M; Xu B; Ghossein RA; Chute DJ; Weigelt B; Jungbluth AA
Mod Pathol; 2019 Feb; 32(2):205-215. PubMed ID: 30206411
[TBL] [Abstract][Full Text] [Related]
36. ARID1A deficient undifferentiated spindle cell and rhabdoid sarcoma of the prostate: report of a unique case with emphasis on diagnostic implications.
Xu W; Dong H; Ru G; Zhao M
Diagn Pathol; 2022 Feb; 17(1):22. PubMed ID: 35125107
[TBL] [Abstract][Full Text] [Related]
37. [Combined hepatocellular and cholangiocellular carcinoma: a case report with invasion to the left hepatic duct of hepatocellular carcinoma].
Ogata T; Ohwada S; Fukusato T; Nakamura S; Kawashima Y; Morishita Y; Matsumoto M; Kon Y
Nihon Shokakibyo Gakkai Zasshi; 1996 Jun; 93(6):428-32. PubMed ID: 8752762
[No Abstract] [Full Text] [Related]
38. Combined hepatocellular and cholangiocarcinoma with marked squamous cell carcinoma components arising in non-cirrhotic liver.
Tsuneyama K; Kaizaki Y; Doden K; Kidani E; Harada K; Sasaki M; Nakanuma Y
Pathol Int; 2003 Feb; 53(2):90-7. PubMed ID: 12588436
[TBL] [Abstract][Full Text] [Related]
39. Alterations in DNA Damage Repair Genes in Primary Liver Cancer.
Lin J; Shi J; Guo H; Yang X; Jiang Y; Long J; Bai Y; Wang D; Yang X; Wan X; Zhang L; Pan J; Hu K; Guan M; Huo L; Sang X; Wang K; Zhao H
Clin Cancer Res; 2019 Aug; 25(15):4701-4711. PubMed ID: 31068370
[TBL] [Abstract][Full Text] [Related]
40. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
